a16z Podcast: The Economics of Expensive Medicines
with Andrew Lo (@AndrewWLo) and Jorge Conde (@JorgeCondeBio)
The advent of new gene and cell therapies are beginning to approach that holy grail of medicine—that of a possible cure. But they are also more expensive than any medicines ever sold before. In this episode, MIT economist Andrew Lo and a16z General Partner on the Bio Fund Jorge Conde discuss how exactly we place an economic value on a cure; the questions we still need to figure out, like who should pay for what and how; and how we need to start thinking about handling the coming influx of highly priced medicines like these into our…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.